[Survival factors in the treatment of hereditary retinal degeneration]

R Frigg1, A Wenzel, C Grimm

  • 1Labor für Zellbiologie der Netzhaut, Departement für Ophthalmologie des Universitätsspitals, Zürich, Schweiz. Enrico.Frigg@usz.ch

Insights

Treatments for inherited retinal degeneration can slow photoreceptor loss but not stop it. Gene therapy in a dog model successfully restored retinal function, showing promise for future human therapies.

Area of Science:

  • Ophthalmology
  • Genetics
  • Cell Biology

Context:

  • Inherited retinal degeneration involves progressive photoreceptor cell death.
  • Current treatments can slow but not halt disease progression.
  • Understanding apoptotic pathways is crucial for developing effective therapies.

Purpose:

  • To review the current state of treatments for inherited retinal degeneration.
  • To highlight the limitations of existing anti-apoptotic strategies.
  • To discuss the potential of gene therapy as demonstrated in a canine model.

Summary:

  • Hereditary retinal degeneration leads to photoreceptor apoptosis, with current interventions only slowing the process.
  • Preserving retinal structure does not guarantee restored visual function (e.g., electroretinography).
  • Gene therapy in a canine model of Leber's congenital amaurosis successfully restored retinal function, proving the method's efficacy.

Impact:

  • Highlights the need for deeper understanding of pro- and anti-apoptotic networks for viable human therapies.
  • Suggests gene therapy as a promising therapeutic approach for inherited retinal disorders.
  • Emphasizes the potential for restoring retinal function, not just preserving morphology.